‘Little benefit’ in early scans for shoulder pain A new review suggests GP support and patient self-management are more beneficial than unnecessary scans and for improving outcomes.
TGA issues urgent melanotan II tanning product warning Dubbed ‘Barbie drugs’ by influencers, laboratory testing has confirmed varying doses of the substance in seized items.
PBAC backs triptorelin PBS expansion It recommends the listing be expanded to support several women’s health conditions, in the wake of Zoladex’s removal from Aussie shelves.
Bird flu threat ‘very low’ for humans: CSIRO Australia’s H5N1 outbreak is prompting vigilance among authorities, but experts say human transmission risk remains low.
Price talks continue as Health Minister pushes for GLP-1 PBS access An agreed price is the main barrier to getting an expanded listing of the ‘revolutionary class of drugs’ on the PBS, Mark Butler has said in latest updates.
RACGP endorses updated prostate cancer guideline The first major update in a decade signals a shift in focus to early detection of clinically significant prostate cancer.
Stimulants driving ‘concerning’ rise in harm Latest data shows amphetamine-type stimulants account for most of the overall increase in drug-related hospitalisations and deaths.
New GP course targets barriers keeping men from healthcare Movember has launched free online training to help primary care recognise hidden signs, build trust and keep male patients engaged.
‘Ongoing risk’ as vitamin B6 warnings fail to dent sales New findings show ‘high-risk vitamin B6 purchasing behaviours’ remain widespread, ‘highlighting the importance for GPs in taking a careful history’.
‘Milestone’ Alzheimer’s diagnosis blood test gets green light GPs could one day be offering patients the ‘holy grail’ test, which could detect biomarkers up to two decades before symptoms appear.